Quan Vu

Insider Reports History

Entity
Individual
Location
22616 Erwin Street, Woodland Hills, CA
Signature
/s/ Quan Vu
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Quan Vu:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ocugen, Inc. CFO/CBO Common Stock 166K $108K $0.65 Mar 6, 2023 Direct
180 Life Sciences Corp. COO / Chief Business Officer Common Stock 20.5K $3.85K $0.19 Dec 16, 2021 Direct
Monopar Therapeutics Chief Financial Officer Stock Options 25K Mar 3, 2025 Direct

Insider Reports Filed by Quan Vu

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MNPR Monopar Therapeutics Mar 3, 2025 1 $0 4 Mar 5, 2025 Chief Financial Officer
MNPR Monopar Therapeutics Mar 3, 2025 0 $0 3 Mar 5, 2025 Chief Financial Officer
OCGN Ocugen, Inc. Mar 6, 2023 0 $0 3 Mar 10, 2023 CFO/CBO
ATNF 180 Life Sciences Corp. Dec 16, 2021 1 $31.8K 4 Dec 16, 2021 COO / Chief Business Officer
ATNF 180 Life Sciences Corp. Dec 10, 2021 1 $17.6K 4 Dec 10, 2021 COO / Chief Business Officer
ATNF 180 Life Sciences Corp. Dec 8, 2021 1 $0 4 Dec 10, 2021 COO / Chief Business Officer
ATNF 180 Life Sciences Corp. Oct 29, 2021 0 $0 3 Nov 4, 2021 COO / Chief Business Officer